Large Study Affirms Cardiovascular Safety of COVID-19 Vaccines in England
Source-Newsmedical.net Assessing Vaccine Safety in a Pandemic A recent study published in Nature Communications provides robust evidence supporting the cardiovascular safety of COVID-19 vaccines among millions of adults in England. Amid the global health crisis caused by the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development and distribution of vaccines were pivotal in mitigating the pandemic’s impact. By autumn 2023, approximately 90% of the population in England aged 12 and above had received at least one dose of a COVID-19 vaccine, significantly reducing the virus’s spread and severity. Despite the overwhelming success of these vaccines in preventing COVID-19-related deaths—estimated at about 14.4 million globally in the first year alone—there have been concerns regarding rare cardiovascular complications following vaccination. Adenovirus-based vaccines, such as ChAdOx1, have been linked to vaccine-induced thrombotic thrombo...